• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖皮质激素受体突变体在活细胞核内表现出更高的运动性:光漂白后荧光恢复时间(FRAP)是受体功能的综合指标。

Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: time of fluorescence recovery after photobleaching (FRAP) is an integrated measure of receptor function.

作者信息

Kino Tomoshige, Liou Szu-Heng, Charmandari Evangelia, Chrousos George P

机构信息

Pediatric Endocrinology Section, Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development. National Institutes of Health, Bethesda, MD 20892-1109, USA.

出版信息

Mol Med. 2004 Jul-Dec;10(7-12):80-8. doi: 10.2119/2005-00026.Kino.

DOI:10.2119/2005-00026.Kino
PMID:16307173
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1431369/
Abstract

Natural mutations of the human glucocorticoid receptor (GR) isoform alpha cause the glucocorticoid resistance syndrome. Mutant receptors may have abnormal interactions with the ligand, target DNA sequences, and/or multiple intracellular proteins, as well as aberrant nucleocytoplasmic trafficking. Using fluorescence recovery after photobleaching (FRAP) analysis, all GR pathologic mutant receptors examined, as well as 2 synthetic GR mutants lacking the activation function (AF)-1 or the ligand-binding domain (and hence the AF-2), had defective transcriptional activity and dynamic motility defects inside the nucleus of living cells. In the presence of dexamethasone, these mutants displayed a curtailed 50% recovery time (t 1/2) after photobleaching and, hence, significantly increased intranuclear motility and decreased "chromatin retention." The t 1/2 values of the mutants correlated positively with their transcriptional activities and depended on the GR domain affected. GRbeta, a natural splice variant of the GR gene, also demonstrated a shorter t 1/2 than GRalpha. The motility responsiveness of the natural and artificial mutant receptors examined, and of GRbeta, to the proteasomal inhibitor MG-132 also depended on the mutant domain. Thus, mutant glucocorticoid receptors possess dynamic motility defects in the nucleus, possibly caused by their inability to properly interact with all key partner nuclear molecules necessary for full activation of glucocorticoid-responsive genes.

摘要

人类糖皮质激素受体(GR)α亚型的自然突变会导致糖皮质激素抵抗综合征。突变受体可能与配体、靶DNA序列和/或多种细胞内蛋白发生异常相互作用,以及出现异常的核质转运。通过光漂白后荧光恢复(FRAP)分析,所有检测的GR病理性突变受体,以及2种缺乏激活功能(AF)-1或配体结合域(从而缺乏AF-2)的合成GR突变体,在活细胞核内均具有缺陷的转录活性和动态运动缺陷。在地塞米松存在的情况下,这些突变体在光漂白后显示出缩短的50%恢复时间(t1/2),因此,核内运动显著增加,“染色质保留”减少。突变体的t1/2值与其转录活性呈正相关,并取决于受影响的GR结构域。GRβ是GR基因的天然剪接变体,其t1/2也比GRα短。所检测的天然和人工突变受体以及GRβ对蛋白酶体抑制剂MG-132的运动反应性也取决于突变结构域。因此,突变糖皮质激素受体在细胞核中存在动态运动缺陷,这可能是由于它们无法与糖皮质激素反应基因完全激活所需的所有关键核伴侣分子进行适当相互作用所致。

相似文献

1
Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: time of fluorescence recovery after photobleaching (FRAP) is an integrated measure of receptor function.糖皮质激素受体突变体在活细胞核内表现出更高的运动性:光漂白后荧光恢复时间(FRAP)是受体功能的综合指标。
Mol Med. 2004 Jul-Dec;10(7-12):80-8. doi: 10.2119/2005-00026.Kino.
2
Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking.病理性人类糖皮质激素受体(GR)突变体通过抑制野生型GR向细胞核的转运,对其产生反式显性负效应:配体结合域对细胞内GR转运的重要性。
J Clin Endocrinol Metab. 2001 Nov;86(11):5600-8. doi: 10.1210/jcem.86.11.8017.
3
Molecular determinants of glucocorticoid receptor mobility in living cells: the importance of ligand affinity.活细胞中糖皮质激素受体流动性的分子决定因素:配体亲和力的重要性。
Mol Cell Biol. 2003 Mar;23(6):1922-34. doi: 10.1128/MCB.23.6.1922-1934.2003.
4
Three Novel Heterozygous Point Mutations of NR3C1 Causing Glucocorticoid Resistance.导致糖皮质激素抵抗的NR3C1基因的三种新型杂合点突变
Hum Mutat. 2016 Aug;37(8):794-803. doi: 10.1002/humu.23008. Epub 2016 May 11.
5
Identification of the functional domain of glucocorticoid receptor involved in RU486 antagonism.鉴定参与RU486拮抗作用的糖皮质激素受体功能域。
J Steroid Biochem Mol Biol. 2009 Oct;117(1-3):67-73. doi: 10.1016/j.jsbmb.2009.07.005. Epub 2009 Jul 25.
6
Glucocorticoid receptor dimerization in the cytoplasm might be essential for nuclear localization.细胞质中的糖皮质激素受体二聚化可能对核定位至关重要。
Biochem Biophys Res Commun. 2021 May 14;553:154-159. doi: 10.1016/j.bbrc.2021.03.071. Epub 2021 Mar 24.
7
Discovery of a functional glucocorticoid receptor beta-isoform in zebrafish.斑马鱼中功能性糖皮质激素受体β亚型的发现。
Endocrinology. 2008 Apr;149(4):1591-9. doi: 10.1210/en.2007-1364. Epub 2007 Dec 20.
8
A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.GR的一种新型C末端显性负性突变通过与p160类固醇受体共激活因子的异常相互作用导致家族性糖皮质激素抵抗。
J Clin Endocrinol Metab. 2002 Jun;87(6):2658-67. doi: 10.1210/jcem.87.6.8520.
9
Protein 14-3-3sigma interacts with and favors cytoplasmic subcellular localization of the glucocorticoid receptor, acting as a negative regulator of the glucocorticoid signaling pathway.蛋白质14-3-3σ与糖皮质激素受体相互作用并促进其细胞质亚细胞定位,作为糖皮质激素信号通路的负调节因子发挥作用。
J Biol Chem. 2003 Jul 11;278(28):25651-6. doi: 10.1074/jbc.M302818200. Epub 2003 May 1.
10
Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRalphaR477H and hGRalphaG679S associated with generalized glucocorticoid resistance.与全身性糖皮质激素抵抗相关的天然人类糖皮质激素受体(hGR)突变体hGRαR477H和hGRαG679S的功能特性
J Clin Endocrinol Metab. 2006 Apr;91(4):1535-43. doi: 10.1210/jc.2005-1893. Epub 2006 Jan 31.

引用本文的文献

1
Glucocorticoid receptor epigenetic activity in the heart.心脏中糖皮质激素受体的表观遗传活性。
Epigenetics. 2025 Dec;20(1):2468113. doi: 10.1080/15592294.2025.2468113. Epub 2025 Feb 25.
2
The Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity.糖皮质激素受体:亚型、功能及其对糖皮质激素敏感性的贡献。
Endocr Rev. 2024 Jul 12;45(4):593-624. doi: 10.1210/endrev/bnae008.
3
Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia.急性淋巴细胞白血病中控制糖皮质激素耐药性的新兴表观遗传和翻译后机制
Hemasphere. 2023 Jun 22;7(7):e916. doi: 10.1097/HS9.0000000000000916. eCollection 2023 Jul.
4
The Utility of Fluorescence Recovery after Photobleaching (FRAP) to Study the Plasma Membrane.光漂白后荧光恢复(FRAP)用于研究质膜的效用。
Membranes (Basel). 2023 May 2;13(5):492. doi: 10.3390/membranes13050492.
5
Posttranslational Modifications of the Mineralocorticoid Receptor and Cardiovascular Aging.盐皮质激素受体的翻译后修饰与心血管衰老
Front Mol Biosci. 2021 May 28;8:667990. doi: 10.3389/fmolb.2021.667990. eCollection 2021.
6
DNA residence time is a regulatory factor of transcription repression.DNA停留时间是转录抑制的一个调控因子。
Nucleic Acids Res. 2017 Nov 2;45(19):11121-11130. doi: 10.1093/nar/gkx728.
7
Negative Correlation between the Diffusion Coefficient and Transcriptional Activity of the Glucocorticoid Receptor.糖皮质激素受体的扩散系数与转录活性之间的负相关
Int J Mol Sci. 2017 Aug 25;18(9):1855. doi: 10.3390/ijms18091855.
8
Glucocorticoid receptor control of transcription: precision and plasticity via allostery.糖皮质激素受体对转录的调控:通过变构实现的精确性和可塑性
Nat Rev Mol Cell Biol. 2017 Mar;18(3):159-174. doi: 10.1038/nrm.2016.152. Epub 2017 Jan 5.
9
Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes.Chrousos 综合征:一篇开创性的报告、一个进化之谜,以及糖皮质激素信号改变的临床意义。
Eur J Clin Invest. 2010 Oct;40(10):932-42. doi: 10.1111/j.1365-2362.2010.02336.x. Epub 2010 Aug 19.
10
The human glucocorticoid receptor: molecular basis of biologic function.人类糖皮质激素受体:生物学功能的分子基础。
Steroids. 2010 Jan;75(1):1-12. doi: 10.1016/j.steroids.2009.09.002. Epub 2009 Oct 7.

本文引用的文献

1
G protein beta interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus.G蛋白β亚基与糖皮质激素受体相互作用并抑制其在细胞核中的转录活性。
J Cell Biol. 2005 Jun 20;169(6):885-96. doi: 10.1083/jcb.200409150. Epub 2005 Jun 13.
2
Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes.翻译调控机制产生具有独特转录靶基因的N端糖皮质激素受体亚型。
Mol Cell. 2005 Apr 29;18(3):331-42. doi: 10.1016/j.molcel.2005.03.025.
3
Rush hour at the promoter: how the ubiquitin-proteasome pathway polices the traffic flow of nuclear receptor-dependent transcription.启动子处的高峰时段:泛素-蛋白酶体途径如何调控核受体依赖性转录的信息流
J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):139-51. doi: 10.1016/j.jsbmb.2004.12.015. Epub 2005 Feb 5.
4
Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors.将泛素-蛋白酶体途径与核受体介导的染色质重塑/修饰联系起来。
J Mol Endocrinol. 2005 Apr;34(2):281-97. doi: 10.1677/jme.1.01680.
5
A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.人类糖皮质激素受体(hGR)配体结合域(LBD)中的一种新型点突变导致全身性糖皮质激素抵抗:hGR LBD C末端在赋予反式激活活性中的重要性。
J Clin Endocrinol Metab. 2005 Jun;90(6):3696-705. doi: 10.1210/jc.2004-1920. Epub 2005 Mar 15.
6
Alternative effects of the ubiquitin-proteasome pathway on glucocorticoid receptor down-regulation and transactivation are mediated by CHIP, an E3 ligase.泛素-蛋白酶体途径对糖皮质激素受体下调和反式激活的不同作用由E3连接酶CHIP介导。
Mol Endocrinol. 2005 Jun;19(6):1474-82. doi: 10.1210/me.2004-0383. Epub 2005 Mar 10.
7
The human glucocorticoid receptor (hGR) beta isoform suppresses the transcriptional activity of hGRalpha by interfering with formation of active coactivator complexes.人糖皮质激素受体(hGR)β亚型通过干扰活性共激活因子复合物的形成来抑制hGRα的转录活性。
Mol Endocrinol. 2005 Jan;19(1):52-64. doi: 10.1210/me.2004-0112. Epub 2004 Sep 30.
8
Subnuclear trafficking and gene targeting by steroid receptors.类固醇受体的核内运输与基因靶向作用
Ann N Y Acad Sci. 2004 Jun;1024:213-20. doi: 10.1196/annals.1321.002.
9
Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms.家族性/散发性糖皮质激素抵抗:临床表型与分子机制
Ann N Y Acad Sci. 2004 Jun;1024:168-81. doi: 10.1196/annals.1321.014.
10
Glucocorticoid and mineralocorticoid receptors and associated diseases.糖皮质激素和盐皮质激素受体及相关疾病。
Essays Biochem. 2004;40:137-55. doi: 10.1042/bse0400137.